Nobel Prize 2025: Regulatory T cells

1. Offord C. Research on immune system’s ‘police’ garners Nobel. Science. 2025;390(6769):112-113. doi: 10.1126/science.aec9015

2. Shi P, Yu Y, Xie H, Yin X, Chen X, Zhao Y, et al. Recent advances in regulatory immune cells: exploring the world beyond Tregs. Front Immunol. 2025;16:1530301. doi: 10.3389/fimmu.2025.1530301

3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3):1151-1164.

4. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27(1):68-73. doi: 10.1038/83784

5. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27(1):18-20. doi: 10.1038/83707

6. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20-21. doi: 10.1038/83713

7. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057-1061. doi: 10.1126/science.1079490

8. Wing JB, Tanaka A, Sakaguchi S. Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity. 2019;50(2):302-316. doi: 10.1016/j.immuni.2019.01.020

9. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 2006;126(2):375-387. doi: 10.1016/j.cell.2006.05.042

10. Zhang R, Miao J, Zhu P. Regulatory T cell heterogeneity and therapy in autoimmune diseases. Autoimmun Rev. 2021;20(5):102715. doi: 10.1016/j.autrev.2020.102715

11. Khan A, Roy P, Ley K. Breaking tolerance: The autoimmune aspect of atherosclerosis. Nat Rev Immunol. 2024;24(9):670-679. doi: 10.1038/s41577-024-01010-y

12. Wang L, Liang Y, Zhao C, Ma P, Zeng S, Ju D, et al. Regulatory T cells in homeostasis and disease: Molecular mechanisms and therapeutic potential. Signal Transduct Target Ther. 2025;10(1):345. doi: 10.1038/s41392-025-02326-4

13. Raffin C, Vo LT, Bluestone JA. Treg cell-based therapies: Challenges and perspectives. Nat Rev Immunol. 2020;20(3):158-172. doi: 10.1038/s41577-019-0232-6

14. Wright RC, Campbell DJ, Levings MK. Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity. Curr Opin Immunol. 2025;94:102554. doi: 10.1016/j.coi.2025.102554

15. Rudensky AY. Regulatory T cells and Foxp3. Immunol Rev. 2011;241(1):260-268. doi: 10.1111/j.1600-065X.2011.01018.x

16. Hu W, Wang ZM, Feng Y, Schizas M, Hoyos BE, van der Veeken J, et al. Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity. Nat Immunol. 2021;22(9):1163-1174. doi: 10.1038/s41590-021-01001-4

17. Avdeeva A, Rubtsov Y, Dyikanov D, Popkova T, Nasonov E. Regulatory T cells in patients with early untreated rheumatoid arthritis: Phenotypic changes in the course of methotrexate treatment. Biochimie. 2020;174:9-17. doi: 10.1016/j.biochi.2020.03.014

18. Nasonov EL, Aleksandrova EN, Avdeeva AS, Rubtsov YuP. T-regulatory cells in rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014;52(4):430-437 (In Russ.). doi: 10.14412/1995-4484-2014-430-437

19. Avdeeva AS, Rubtsov YuP, Dyikanov DT, Nasonov EL. The clinical and pathogenetic value of Foxp3+ T regulatory cells in rheumatoid arthritis. NauchnoPrakticheskaya Revmatologia = Rheumatology Science and Practice. 2016;54(4):442-455 (In Russ.). doi: 10.14412/1995-44842016-442-455

20. Bykovskaya SN, Nasonov EL. Role of immune suppression defects in the development of autoimmune diseases. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2005;43(4):81-84 (In Russ.). doi: 10.14412/1995-4484-2005-623

21. Lyssuk EY, Torgashina AV, Soloviev SK, Nassonov EL, Bykovskaia SN. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol. 2007;601:113-119.